GlassScriptPhysician profile
Mallory Gail Crownover
NPI 1700390721
$6,065.21
in general payments reported to CMS, 2019-2025
46 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,009 · 2022: $1,216 · 2023: $901 · 2024: $579 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,824 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,823.97 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $749.15 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $697.87 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $598.18 | 2021-2025 | |
| Lilly USA, LLC | $394.34 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $337.67 | 2021-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $313.27 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $253.62 | 2021-2025 | |
| Novo Nordisk INC | $234.36 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.20 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $194.52 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $186.53 | 2021-2025 | Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $181.97 | 2021-2024 | Spravato, Xarelto |
| Madrigal Pharmaceuticals | $159.56 | 2025 | Rezdiffra |
| Astellas Pharma US INC | $151.14 | 2021-2022 | |
| Celgene Corporation | $109.58 | 2022-2023 | Eliquis |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $96.20 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $88.70 | 2022-2025 | Gvoke Hypopen, Keveyis |
| Daiichi Sankyo INC. | $84.48 | 2021-2025 | Injectafer |
| Abbott Laboratories | $79.93 | 2022-2023 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $75.35 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $72.89 | 2022-2023 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $66.38 | 2021-2023 | Seglentis, Livalo |
| Aimmune Therapeutics, INC. | $58.35 | 2024-2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $54.40 | 2021-2023 | |
| Corcept Therapeutics | $50.28 | 2025 | Korlym |
| Mannkind Corporation | $47.18 | 2021 | |
| Horizon Therapeutics Plc | $46.77 | 2022-2023 | Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $45.75 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.61 | 2025 | Gardasil 9, Vaxelis, M-M-R II |
| Biohaven Pharmaceutical Holding Company LTD. | $35.97 | 2022 | |
| Boston Scientific Corporation | $32.86 | 2025 | Versacross Steerable Access Solution |
| Edwards Lifesciences Corporation | $26.07 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kyowa Kirin, INC. | $25.41 | 2023 | Crysvita |
| Lundbeck LLC | $24.10 | 2021 | |
| Amarin Pharma, INC. | $23.46 | 2021 | |
| Zealand Pharma US, INC. | $22.27 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $21.38 | 2021 | |
| Radius Health, INC. | $20.90 | 2022 | |
| Dexcom, INC. | $19.93 | 2024 | Dexcom G6 Transmitter |
| Baxter Healthcare | $18.52 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Eisai INC. | $17.43 | 2021 | |
| Dynavax Technologies Corporation | $16.80 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.45 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Si-Bone, INC. | $14.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Crownover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.